Stocks / NASDAQ / Dipexium Pharmaceuticals, Inc.

Dipexium Pharmaceuticals, Inc.

Company Description

Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. [Source: MarketWatch]

Company Website: http://www.dipexiumpharmaceuticals.com